Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01620541 · ClinicalTrials.gov registry record

Comparing Ankle Fusion to Ankle Replacement

A clinical trial of Osteoarthritis (OA) and End-stage Ankle Arthritis (ESAA), sponsored by Seattle Institute for Biomedical and Clinical Research.

Active
Registry status
516
Enrollment target
6
Study locations

NCT01620541 is a study of Osteoarthritis (OA) and End-stage Ankle Arthritis (ESAA) that is active but no longer recruiting, run by Seattle Institute for Biomedical and Clinical Research. The registered enrollment target is 516 participants. The trial reports 6 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01620541, a study of Osteoarthritis (OA) and End-stage Ankle Arthritis (ESAA), is active but no longer recruiting, sponsored by Seattle Institute for Biomedical and Clinical Research.

ACTIVE NOT RECRUITING
Registry status
516 participants
Enrollment target
6
Study locations

Study Summary

End-stage ankle arthritis (ESAA) is a debilitating condition associated with severe pain, dysfunction, and reduced quality of life. Many patients with ESAA have difficulty walking for even 100 feet or up a single flight of stairs. Patients seeking surgery for ESAA have two primary treatment options: ankle arthrodesis (i.e., ankle fusion) and ankle arthroplasty (i.e., ankle replacement). Few studies have directly compared the effectiveness of these two procedures, and no randomized controlled trials (RCTs) have been performed. The investigators will compare the following in subjects undergoing ankle arthrodesis and ankle arthroplasty before surgery, and post-surgery at 3 and 6 months, and on an annual basis up to ten years. 1. Overall physical function and ankle specific function 2. Ankle pain intensity and interference with activities 3. Activity levels 4. Overall general health 5. Post-surgical complication rates The investigators will also identify prognostic factors that are predictive of higher physical function, ankle specific function, reduced pain, improved general health, and overall patient satisfaction.

Interventions

  • PROCEDURE Ankle Arthrodesis
  • PROCEDURE Ankle Arthroplasty

Study Locations (6)

Washington

  • Harborview Medical Center - Seattle
  • VA Puget Sound Health Care System - Seattle

Colorado

  • Orthopaedic and Spine Center of the Rockies - Fort Collins

Michigan

  • Orthopaedic Associates of Michigan - Grand Rapids

Minnesota

  • Twin Cities Orthopedics - Edina

Oregon

  • Orthopedic + Fracture Specialists - Portland

Trial Details

FieldValue
Enrollment Target 516 participants
Start Date 2012-05
Est. Completion 2027-05

What the Registry Record Tells You About NCT01620541

The ClinicalTrials.gov registry entry for NCT01620541 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 516 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Seattle Institute for Biomedical and Clinical Research, which has 43 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Osteoarthritis (OA) appearing as the primary indexed condition, and to 2 interventions - of which Ankle Arthrodesis is the first listed.

NCT01620541 reports 6 study locations spanning 5 distinct geographic areas - top geographies include Washington, Colorado, Michigan.

Frequently Asked Questions

What is clinical trial NCT01620541 about?

NCT01620541 is a clinical study titled "Comparing Ankle Fusion to Ankle Replacement". End-stage ankle arthritis (ESAA) is a debilitating condition associated with severe pain, dysfunction, and reduced quality of life. Many patients with ESAA have difficulty walking for even 100 feet or up a single flight of stairs. Patients seeking surgery for ESAA have two primary treatment options:...

What is the current status of trial NCT01620541?

This trial is currently active not recruiting. The enrollment target is 516 participants. The study started on 2012-05. Estimated completion is 2027-05.

What conditions does trial NCT01620541 study?

This clinical trial studies the following conditions: Osteoarthritis (OA), End-stage Ankle Arthritis (ESAA).

What interventions are being tested in trial NCT01620541?

The interventions under investigation include: Ankle Arthrodesis (PROCEDURE), Ankle Arthroplasty (PROCEDURE).

Who is sponsoring clinical trial NCT01620541?

This trial is sponsored by Seattle Institute for Biomedical and Clinical Research, which has 43 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01620541 being conducted?

This trial has 6 study locations across Colorado, Michigan, Minnesota, Oregon, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Osteoarthritis (OA)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.